Home
Conditions
Lipid Metabolism, Inborn Errors

Clinical trial condition

Lipid Metabolism, Inborn Errors

Explore clinical trials studying Lipid Metabolism, Inborn Errors. Study availability and eligibility vary by location and protocol.

834 public trials 155 recruiting studies

Refine in advanced search Browse all conditions

Lipid Metabolism, Inborn Errors trial results

Completed

Drug-Drug Interaction Study Between AT1001 (Migalastat Hydrochloride) and Agalsidase in Participants With Fabry Disease

NCT01196871

Conditions: Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +19 more
Locations: Birmingham, Alabama, United States

Decatur, Georgia, United States

Iowa City, Iowa, United States

Kansas City, Kansas, United States

View Trial Details

Completed

Safety, Tolerability and Pharmacokinetics of SBC-102 (Sebelipase Alfa) in Adult Participants With Lysosomal Acid Lipase Deficiency

NCT01307098

Conditions: Cholesterol Ester Storage Disease, Cholesterol Ester Storage Disease(CESD), Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +12 more
Locations: Stanford, California, United States

New York, United States

Pittsburgh, Pennsylvania, United States

Prague, Czechia

View Trial Details

Completed

Trial Evaluating PCSK9 Antibody in Subjects With LDL Receptor Abnormalities

NCT01588496

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemias, Genetic Diseases, Inborn, +10 more
Locations: Research Site New York, United States

Research Site Cincinnati, Ohio, United States

Research Site Brussels, Belgium

Research Site La Louvière, Belgium

View all 21 locations

View Trial Details

Completed

Study to Compare the Efficacy and Safety of Oral AT1001 and Enzyme Replacement Therapy in Patients With Fabry Disease

NCT01218659

Conditions: Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +19 more
Locations: Los Angeles, California, United States

Aurora, Colorado, United States

Decatur, Georgia, United States

Grand Rapids, Michigan, United States

View all 25 locations

View Trial Details

Completed

A 12-Week Safety and Pharmacodynamic Study of AT1001 (Migalastat Hydrochloride) in Participants With Fabry Disease

NCT00283959

Conditions: Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +19 more
Locations: Parkville, Australia

Porto Alegre, Brazil

View Trial Details

Completed

A Study of AT1001 (Migalastat Hydrochloride) in Participants With Fabry Disease

NCT00214500

Conditions: Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +19 more
Locations: Los Angeles, California, United States

Decatur, Georgia, United States

Bethesda, Maryland, United States

New York, United States

View Trial Details

Completed

Study of the Effects of Oral AT1001 (Migalastat Hydrochloride) in Patients With Fabry Disease

NCT00925301

Conditions: Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +19 more
Locations: Los Angeles, California, United States

San Francisco, California, United States

Decatur, Georgia, United States

Chicago, Illinois, United States

View all 28 locations

View Trial Details

Completed

Cardiac Involvement in Adult Patients With Fabry Disease; Relation to Enzyme Replacement Therapy

NCT02908724

Conditions: Aortic Stenosis, Subvalvular, Aortic Valve Disease, Aortic Valve Stenosis, +31 more
Locations: Not specified

View Trial Details

Completed

Fabry: Renal Function During Long-term ERT by 51Cr-EDTA Clearance

NCT02969200

Conditions: Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +25 more
Locations: National University Hospital, Department of Medical Endocrinology Copenhagen, Denmark

View Trial Details

Completed

Efficacy and Safety of Lomitapide in Japanese Patients With HoFH on Concurrent Lipid-Lowering Therapy

NCT02173158

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemias, Familial Hypercholesterolemia - Homozygous, +10 more
Locations: Kurume-shi, Fukuoka, Japan

Kanazawa, Ishikawa-ken, Japan

Osakashi, Osaka, Japan

Suita-shi, Osaka, Japan

View Trial Details

Lipid Metabolism, Inborn Errors

Lipid Metabolism, Inborn Errors trial results

Related conditions